When researching mesothelioma, many factors arise regarding cause and prevention of treatment. One of the potential things that many people don’t know about is the presence or absence of the PD-L1 protein and how it impacts cancerous diseases.
So, what is this protein? How does it impact a person who has mesothelioma? It starts with recognizing the role that PD-L1 has inside your body.
Hiding a Tumor
Your body’s immune system fights off—or attempts to fight off—anything from colds and fevers to mesothelioma cancer cells. It finds the problems throughout your body and attacks it to try and help you recover as much as possible.
The PD-L1 protein, however, helps to hide tumors from your immune system. The higher your PD-L1 levels, the more difficult it is for your immune system to work, and the harder it is to detect your tumors. Hidden tumors and cells can make it difficult to diagnose mesothelioma, let alone come up with an effective treatment option.
Treatments to Target PD-L1
As more becomes known about PD-L1, researchers are attempting to come up with a plan regarding which treatments can fight against the protein. To this point, researchers have determined pembrolizumab, nivolumab, and avelumab as three medications to block PD-L1 and increase the visibility of cancer cells.
Because the treatment medication is effective to remove the occurrence of PD-L1, you must rely on the use of other treatment options that help with treating mesothelioma. It can be difficult to understand how this protein harms you, so it’s best to discuss your options with your doctor.
Our mesothelioma lawyers at Shrader & Associates, L.L.P. can help you through the legal battles that lie ahead. You can get justice—you just need to understand the ways in which negligence led to you suffering from mesothelioma. Let us help you recognize your rights.
Call our firm today at (877) 958-7920 and speak with an attorney about your needs.